Cardiac toxicity of coxibs: mechanisms of development and their prevention
Development of highly selective COX-2 inhibitors – coxibs has proved a decreased risk of gastrointestinal toxicity, which was typical for non-selective NSAIDS, according to the evidence-based medicine. But such situation caused an imbalance in the impact on the synthesis of arachidonic acid metaboli...
Main Authors: | O O Yakovleva, A O Zhamba, I O Doroshkevych, T K Vitruk |
---|---|
Format: | Article |
Language: | English |
Published: |
Interdisciplinary Academy of Pain Medicine
2018-11-01
|
Series: | Медицина болю |
Subjects: | |
Online Access: | https://painmedicine.org.ua/index.php/pnmdcn/article/view/154 |
Similar Items
-
Risk of incident active tuberculosis disease in patients treated with non-steroidal anti-inflammatory drugs: a population-based study
by: Chun-Wei Wu, et al.
Published: (2017-05-01) -
Defined Daily Dose and Appropriateness of Clinical Application: The Coxibs and Traditional Nonsteroidal Anti-Inflammatory Drugs for Postoperative Orthopaedics Pain Control in a Private Hospital in Malaysia
by: Faizah Safina Bakrin, et al.
Published: (2020-12-01) -
Pharmacoutilization of anti-inflammatory and gastroprotective drugs in patients with osteoarthritis: comparison between COXIBs and conventional NSAIDs by using administrative records
by: Luca Degli Esposti, et al.
Published: (2006-01-01) -
Hipersensibilidad selectiva a inhibidores de la ciclooxigenasa-2
by: Laura Romero Sánchez, et al.
Published: (2023-01-01) -
Comprehensive Assessment of the Stability of Selected Coxibs in Variable Environmental Conditions along with the Assessment of Their Potential Hepatotoxicity
by: Paweł Gumułka, et al.
Published: (2023-11-01)